<DOC>
	<DOC>NCT01013909</DOC>
	<brief_summary>The study shall prove whether 6 consecutive doses of Bifonazole spray show comparable efficacy to a Terbinafine solution applied once.</brief_summary>
	<brief_title>Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs Placebo</brief_title>
	<detailed_description />
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Terbinafine</mesh_term>
	<mesh_term>Bifonazole</mesh_term>
	<criteria>Male or female subjects aged between 18 and 70 years Positive clinical findings of athlete's foot, limited to interdigital spaces, with a total athlete's foot severity score (AFSS) of at least 5 and not exceeding 10 points for the signs and symptoms of athlete's foot, and no sign or symptom scoring 'severe' Clinical history suggestive of intolerance or allergies to one of the products or the ingredients of the products Plantar tinea pedis ("Mocassintype") Onychomycosis of any toe Previous treatment with a systemic antifungal within 6 months prior to screening Previous treatment of feet with a topical antifungal within 4 weeks prior to screening Previous treatment with a topical antifungal applied to other areas of the body than feet within 2 weeks prior to screening Previous treatment of any topical medication applied to the feet within 2 weeks prior to screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Bifonazole</keyword>
	<keyword>Terbinafine</keyword>
	<keyword>Reduced treatment duration</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
	<keyword>Athlete's foot</keyword>
	<keyword>Moderate severity</keyword>
</DOC>